Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Filament Biosciences LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being handled by 1 distinct examiner and is situated within a distinct art unit. This concentration suggests that the company's current patent activity is focused on a specific technical innovation within the biotechnology sector.
The busiest examiner for the portfolio is Swift, Candice Lee, who is managing the single pending office action. Since this is the only pending action for the company, Swift, Candice Lee is the primary official overseeing the applicant's current work. For a practitioner, this means that the prosecution strategy is streamlined, as it involves only a single examiner and a single art unit.
Operating within the Biotechnology & Pharmaceuticals area often involves complex examination, but with only a single pending office action, the company can focus its resources on this specific case. The involvement of a distinct art unit means the applicant only needs to navigate the procedures of one section of the patent office. This focused approach allows for a very targeted prosecution effort.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18444307 | PROCESS FOR FRACTIONATION OF PHOTOSYNTHETIC BIOMASS AND RELATED SYSTEMS AND METHODS | SWIFT, CANDICE LEE | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18444307 | PROCESS FOR FRACTIONATION OF PHOTOSYNTHETIC BIOMASS AND RELATED SYSTEMS AND METHODS | SWIFT, CANDICE LEE | 12d |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18444307 | PROCESS FOR FRACTIONATION OF PHOTOSYNTHETIC BIOMASS AND RELATED SYSTEMS AND METHODS | SWIFT, CANDICE LEE | 1657 | §103§112 | Non-Final OA | 12d | Pending | Feb 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial